FR2854640A1 - Genes du psoriasis - Google Patents

Genes du psoriasis

Info

Publication number
FR2854640A1
FR2854640A1 FR0305573A FR0305573A FR2854640A1 FR 2854640 A1 FR2854640 A1 FR 2854640A1 FR 0305573 A FR0305573 A FR 0305573A FR 0305573 A FR0305573 A FR 0305573A FR 2854640 A1 FR2854640 A1 FR 2854640A1
Authority
FR
France
Prior art keywords
pmp
gene
psoriasis
expression
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR0305573A
Other languages
English (en)
Inventor
Valerie Trinquet
Patricia Rossio
Michel Demarchez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to FR0305573A priority Critical patent/FR2854640A1/fr
Priority to PCT/FR2004/001065 priority patent/WO2004101821A1/fr
Publication of FR2854640A1 publication Critical patent/FR2854640A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention a pour objet l'utilisation d'une sonde relative au gène PMP69 pour la caractérisation d'un échantillon biologique. L'invention a également pour objet l'utilisation de cette sonde pour l'identification d'un composé destiné au traitement du psoriasis, un procédé d'identification ainsi qu'un nouvel outil de recherche.
FR0305573A 2003-05-07 2003-05-07 Genes du psoriasis Withdrawn FR2854640A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0305573A FR2854640A1 (fr) 2003-05-07 2003-05-07 Genes du psoriasis
PCT/FR2004/001065 WO2004101821A1 (fr) 2003-05-07 2004-05-03 Gene pmp69 du psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0305573A FR2854640A1 (fr) 2003-05-07 2003-05-07 Genes du psoriasis

Publications (1)

Publication Number Publication Date
FR2854640A1 true FR2854640A1 (fr) 2004-11-12

Family

ID=33306223

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0305573A Withdrawn FR2854640A1 (fr) 2003-05-07 2003-05-07 Genes du psoriasis

Country Status (2)

Country Link
FR (1) FR2854640A1 (fr)
WO (1) WO2004101821A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002029103A2 (fr) * 2000-10-02 2002-04-11 Gene Logic, Inc. Profils d'expression genetique dans le cancer du foie
WO2002068579A2 (fr) * 2001-01-10 2002-09-06 Pe Corporation (Ny) Kits tels que des dosages d'acides nucleiques comprenant une majorite d'exons ou de transcrits humains, destines a detecter l'expression et pouvant avoir d'autres applications
US6458838B1 (en) * 1999-09-28 2002-10-01 Johns Hopkins University Adrenoleukodystrophy treatments

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458838B1 (en) * 1999-09-28 2002-10-01 Johns Hopkins University Adrenoleukodystrophy treatments
WO2002029103A2 (fr) * 2000-10-02 2002-04-11 Gene Logic, Inc. Profils d'expression genetique dans le cancer du foie
WO2002068579A2 (fr) * 2001-01-10 2002-09-06 Pe Corporation (Ny) Kits tels que des dosages d'acides nucleiques comprenant une majorite d'exons ou de transcrits humains, destines a detecter l'expression et pouvant avoir d'autres applications

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BOWCOCK A M ET AL: "Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies", HUMAN MOLECULAR GENETICS, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 10, no. 17, 15 August 2001 (2001-08-15), pages 1793 - 1805, XP002265788, ISSN: 0964-6906 *
HOLZINGER A ET AL: "Primary structure of human PMP69, a putative peroxisomal ABC-Transporter", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 237, - 1997, pages 152 - 157, XP000876888 *

Also Published As

Publication number Publication date
WO2004101821A1 (fr) 2004-11-25

Similar Documents

Publication Publication Date Title
Burns et al. Associations between coping strategies and mental health in individuals with type 2 diabetes: Prospective analyses.
Dabra et al. Evaluating the levels of salivary alkaline and acid phosphatase activities as biochemical markers for periodontal disease: A case series
EP1556405A4 (fr) Mutations de nod2 associees a la stenose fibreuse chez des patients souffrant de la maladie de crohn
GB0524110D0 (en) Biomarkers and methods for identification of agents useful in the treatment of affective disorders
Khiste et al. Critical analysis of biomarkers in the current periodontal practice
WO2005100603A3 (fr) Procedes de decollement de bande pour l'analyse de maladie et la peau et d'etat pathologique de la peau
WO2005106026B1 (fr) Utilisation de genes comme marqueurs moleculaires dans le diagnostic de la schizophrenie et kit de diagnostic associe
MX2007006529A (es) Seleccionar pacientes para terapia con un inhibidor her.
PL2848938T3 (pl) Ocena skuteczności leczenia u osobnika na podstawie poziomów ST2
WO2006133287A3 (fr) Profils d'expression des cellules mononucleaires du sang peripherique pour le traitement des maladies intestinales inflammatoires
AU2003213594A1 (en) Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples
Sellappa et al. Micronucleus test in exfoliated buccal cells from chromium exposed tannery workers
JP2008178390A (ja) 皮膚の状態を評価する方法及びその用途
Chen et al. Imaging of formaldehyde fluxes in epileptic brains with a two-photon fluorescence probe
SG161216A1 (en) A method of diagnosis and treatment and agents useful for same
Chiu et al. The effects of lead exposure on the activities of δ-aminolevulinic acid dehydratase with the modification of the relative genotypes
Wagner Optimal Use of Serum Enzyme Levels in the Diagnosis of Acute Myocardial Infarction: The Perspective in 1980
Eick et al. Persistence of Porphyromonas gingivalis is a negative predictor in patients with moderate to severe periodontitis after nonsurgical periodontal therapy
WO2010033951A3 (fr) Procédé d'identification et de prédiction de la sclérose en plaques et de la réponse à la thérapie
WO2003101948A3 (fr) Agents d'imagerie et procedes diagnostiques faisant appel a ces derniers
WO2005079410A3 (fr) Profils biologiques et methodes d'utilisation
FR2854640A1 (fr) Genes du psoriasis
FR2854639A1 (fr) Genes du psoriasis.
WO2003068268A3 (fr) Traitement, diagnostic et imagerie d'une maladie
EP1695092B8 (fr) Methodes de diagnostic prospectif pour composes therapeutiques et methodes permettant de controler un traitement a l'azathioprine

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20080131